IP Library Granted Patent US 12,257,436
Granted Patent B2
US 12,257,436 · App. 17/597,799 · Granted Mar 25, 2025

Neural sensing in an implantable stimulator device during passive charge recovery

Inventors: Kiran K. Gururaj (Valencia, CA); David M. Wagenbach (Simi Valley, CA); Philip L. Weiss (Sherman Oaks, CA); Emanuel Feldman (Simi Valley, CA)
Assignee: Boston Scientific Neuromodulation Corporation
A61N1/36125A61B5/388A61B5/4058A61N1/025A61N1/36135A61N1/36146
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,257,436
App. No.
17/597,799
Granted
Mar 25, 2025
Kind
B2
Abstract

Techniques for sensing neural responses such as Evoked Compound Action Potentials (ECAPs) in an implantable stimulator device are disclosed. A first therapeutic pulse phase is followed by a charge recovery phase that includes at least one high-impedance passive charge recovery duration. The ECAP is sensed during the high-impedance passive charge recovery duration. The time period of the passive charge recovery is lengthened and the high-impedance passive recharge duration entirely overlaps the ECAP (i.e., the neural response duration) at the sensing electrode.

Claims (11)

1. A method for operating a stimulator device, the stimulator device comprising a plurality of electrode nodes, each electrode node configured to be coupled to one of a plurality of electrodes configured to contact a patient's tissue, the method comprising:

providing actively-driven stimulation at at least one stimulation node selected from the plurality of electrode nodes, wherein the stimulation comprises at least one pulse comprising at least a first phase;

providing passively-driven passive charge recovery for a passive charge recovery duration,

selecting a first recovery impedance for a high-impedance portion of the passive charge recovery duration and a second recovery impedance for a low-impedance portion of the passive charge recovery duration, wherein the first recovery impedance is greater than the second recovery impedance,

using a variable resistance circuitry of the stimulator device to provide the selected recovery impedances during the passive charge recovery duration,

determining a time at which the neural response will be present at the sensing electrode node and timing the passive charge recovery duration so that the high-impedance passive charge recovery portion will overlap the time at which the neural response will be present the sensing electrode node, and

sensing an evoked neural response evoked by the stimulation during the high-impedance passive charge recovery portion at at least one sensing electrode node selected from the plurality of electrode nodes during the passive charge recovery duration.

2. The method of claim 1 , wherein the variable resistance circuitry comprises a plurality of switching circuits, wherein each of the plurality of switching circuits is coupled with a different one of the electrode nodes and is configured, when selected, to provide variable impedance between its respective electrode node and a common node.

3. The method of claim 2 , wherein the common node comprises a reference voltage selected from the group consisting of a battery voltage, a compliance voltage, a fraction of a compliance voltage, and ground.

4. The method of claim 2 , wherein each of the plurality of switching circuits comprises a plurality of switches wherein the switches are selectable to vary the resistance.

5. The method of claim 2 , wherein plurality of switches comprises a plurality of transistors in parallel.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 24, 2022
From: GURURAJ, KIRAN K.; WAGENBACH, DAVID M.; WEISS, PHILIP L.; FELDMAN, EMANUEL
To: BOSTON SCIENTIFIC NEUROMODULATION CORPORATION
Reel/Frame 058747/0451 →
Continuity (2)
Provisional Application 62883452 · Aug 6, 2019
Related Publication 20220233866A1 · Jul 28, 2022
References Cited (90)
US 5697958A · Paul et al. · 1997 [cited by applicant]
US 5702429A · King · 1997 [cited by applicant]
US 5902236A · Iversen · 1999 [cited by applicant]
US 5902249A · Lyster · 1999 [cited by applicant]
US 5913882A · King · 1999 [cited by applicant]
US 6181969B1 · Gord et al. · 2001 [cited by applicant]
US 6516227B1 · Meadows · 2003 [cited by examiner]
US 7024247B2 · Gliner et al. · 2006 [cited by applicant]
US 7424322B2 · Lombardi et al. · 2008 [cited by applicant]
US 7450992B1 · Cameron · 2008 [cited by applicant]
US 8255057B2 · Fang et al. · 2012 [cited by applicant]
US 8335664B2 · Eberle · 2012 [cited by applicant]
US 8352030B2 · Denison · 2013 [cited by applicant]
US 8606362B2 · He et al. · 2013 [cited by applicant]
US 8620436B2 · Parramon et al. · 2013 [cited by applicant]
US 9044155B2 · Strahl · 2015 [cited by applicant]
US 9155892B2 · Parker et al. · 2015 [cited by applicant]
US 9248274B2 · Troosters et al. · 2016 [cited by applicant]
US 9248279B2 · Chen · 2016 [cited by examiner]
US 9265431B2 · Hincapie Ordonez et al. · 2016 [cited by applicant]
US 9302112B2 · Bornzin et al. · 2016 [cited by applicant]
US 9381356B2 · Parker et al. · 2016 [cited by applicant]
US 9386934B2 · Parker et al. · 2016 [cited by applicant]
US 9403013B2 · Walker et al. · 2016 [cited by applicant]
US 9409020B2 · Parker · 2016 [cited by applicant]
US 9526897B2 · Chen et al. · 2016 [cited by applicant]
US 9533148B2 · Carcieri et al. · 2017 [cited by applicant]
US 9731116B2 · Chen · 2017 [cited by applicant]
US 9872990B2 · Parker et al. · 2018 [cited by applicant]
US 9974455B2 · Parker et al. · 2018 [cited by applicant]
US 10076667B2 · Kaula et al. · 2018 [cited by applicant]
US 10881859B2 · Brill et al. · 2021 [cited by applicant]
US 10926092B2 · Esteller et al. · 2021 [cited by applicant]
US 20020156513A1 · Borkan · 2002 [cited by applicant]
US 20050246004A1 · Cameron et al. · 2005 [cited by applicant]
US 20080146894A1 · Bulkes et al. · 2008 [cited by applicant]
US 20120092031A1 · Shi et al. · 2012 [cited by applicant]
US 20120095519A1 · Parramon et al. · 2012 [cited by applicant]
US 20120095529A1 · Parramon et al. · 2012 [cited by applicant]
US 20130289665A1 · Marnfeldt et al. · 2013 [cited by applicant]
US 20140194772A1 · Single et al. · 2014 [cited by applicant]
US 20140236042A1 · Parker et al. · 2014 [cited by applicant]
US 20140296737A1 · Parker et al. · 2014 [cited by applicant]
US 20150119751A1 · Stanslaski et al. · 2015 [cited by applicant]
US 20150157861A1 · Aghassian et al. · 2015 [cited by applicant]
US 20150282725A1 · Single et al. · 2015 [cited by applicant]
US 20150313487A1 · Single et al. · 2015 [cited by applicant]
US 20160166164A1 · Obradovic et al. · 2016 [cited by applicant]
US 20160220820A1 · Zottola · 2016 [cited by applicant]
US 20160287126A1 · Parker et al. · 2016 [cited by applicant]
US 20160287182A1 · Single et al. · 2016 [cited by applicant]
US 20170049345A1 · Single et al. · 2017 [cited by applicant]
US 20170071490A1 · Parker et al. · 2017 [cited by applicant]
US 20170135624A1 · Parker et al. · 2017 [cited by applicant]
US 20170216587A1 · Parker et al. · 2017 [cited by applicant]
US 20170296823A1 · Hershey et al. · 2017 [cited by applicant]
US 20170361101A1 · Single et al. · 2017 [cited by applicant]
US 20180071527A1 · Feldman · 2018 [cited by examiner]
US 20180110987A1 · Parker et al. · 2018 [cited by applicant]
US 20180117335A1 · Parker et al. · 2018 [cited by applicant]
US 20180132747A1 · Parker et al. · 2018 [cited by applicant]
US 20180132760A1 · Parker et al. · 2018 [cited by applicant]
US 20180133459A1 · Parker et al. · 2018 [cited by applicant]
US 20180140831A1 · Feldman et al. · 2018 [cited by applicant]
US 20180228391A1 · Parker et al. · 2018 [cited by applicant]
US 20180228547A1 · Parker et al. · 2018 [cited by applicant]
US 20180256052A1 · Parker et al. · 2018 [cited by applicant]
US 20190099602A1 · Esteller et al. · 2019 [cited by applicant]
US 20190275331A1 · Zhu · 2019 [cited by applicant]
US 20190290900A1 · Esteller et al. · 2019 [cited by applicant]
US 20190299006A1 · Marnfeldt · 2019 [cited by applicant]
US 20190366094A1 · Esteller et al. · 2019 [cited by applicant]
US 20200155019A1 · Esteller et al. · 2020 [cited by applicant]
US 20200305745A1 · Wagenbach et al. · 2020 [cited by applicant]
WO 2015077362 · 2015 [cited by applicant]
WO 2017100866 · 2017 [cited by applicant]
WO 2017173493 · 2017 [cited by applicant]
WO 2017210352 · 2017 [cited by applicant]
WO 2017219096 · 2017 [cited by applicant]
H. Mino & J. Rubenstein, “Effects of Neural Refractoriness on Spatio-Temporal Variability in Spike Initiations with Eletrical Stimulation,” IEEE Trans. On Neural Sys. & Rehabilitation Eng., vol. 14, No. 3, pp. 273-280 (… [cited by applicant]
M. Moffit et al., A Novel 3-Dimensional Algorithm for Model-Based Programming in Spinal Cord Stimuation (SCS): Illumina-3D™, presentation (2013). [cited by applicant]
M. Hughes, “Fundamentals of Clinical ECAP Measures in Cochlear Implants: Part 1: Use of the ECAP in Speech Processor Programming (2nd Ed.),” Audiology Online (Nov. 8, 2010) (http:// www.audiologyonline.com/ articles/ fu… [cited by applicant]
I. Akhoun et al., “Electrically evoked compound action potential artifact rejection by independent component analysis: Technique validation,” Hearing Research 302, pp. 60-73 (2013). [cited by applicant]
J. Rubinstein et al., “Pseudospontaneous activity: stochastic independence of auditory nerve fibers with electrical stimulation,” Hear Res., 127(1-2), pp. 108-118 (1999) (abstract only). [cited by applicant]
J. Paz, “Physiological Midline Mapping Based on Spinal Cord Stimulation (SCS) Response Using the 32-Contact Paddle Lead,” 19 [cited by applicant]
E.L. Air et al., “Electrophysiologic Monitoring for Placement of Laminectomy Leads for Spinal Cord Stimulation Under General Anesthesia,” Neuromodulation: Technology at the Neural Interface, vol. 15(6), pp. 573-580 (201… [cited by applicant]
J.L. Shils et al., “Intraoperative Neurophysiologic Methods for Spinal Cord Stimulator Placement Under General Anesthesia,” Neuromodulation: Technology at the Neural Interface, vol. 15(6), pp. 560-572 (2012). [cited by applicant]
A. Taghva et al., “Intraoperative Electromyography as an Adjunct to Sacral Neuromodulation for Chronic Pelvic Pain,” Neuromodulation: Technology at the Neural Interface, vol. 18(1), pp. 62-66 (2015). [cited by applicant]
International Search Report and Written Opinion regarding corresponding PCT Application No. PCT/US2020/044881, mailed Oct. 15, 2020. [cited by applicant]
First Office Action regarding corresponding Chinese Patent Application No. 202080069764.X, mailed Jul. 4, 2024. [cited by applicant]